| Literature DB >> 31448618 |
Sam Kavoosi1, Debasis Dey1, Kabirul Islam1.
Abstract
A concise synthetic strategy to 5-dihydroxyboryldexoyuridine (5boU) phosphoramidite has been developed. 5boU was introduced into short oligonucleotides in a site-specific manner, demonstrating compatibility of the boronic acid moiety with standard solid-phase DNA synthesis chemistry. Electrophilic 5boU DNAs inhibited thymine DNA glycosylase, a cancer-relevant DNA-modifying enzyme. We envisage diverse applications of 5boU in organic synthesis, medicinal chemistry, and chemical biology.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31448618 PMCID: PMC7042053 DOI: 10.1021/acs.orglett.9b02042
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005